Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Boston Therapeutics Inc (OTCQB:BTHE)

0.0697
Delayed Data
As of Aug 16
 0.00 / 0.00%
Today’s Change
0.04
Today|||52-Week Range
0.17
-0.43%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues323.4K199.6K98.9K98.9K
 
 
 
 
 
Cost of Goods Sold211.1K104.9K169.4K23.8K
 
 
 
 
 
Depreciation And Amortization67.1K70.9K71.0K70.4K
 
 
 
 
 
 
Operating ExpensesGross Income45.2K23.8K-141.5K4.7K
 
 
 
 
 
General Expenses4.6M4.7M2.0M1.3M
 
 
 
 
 
Research And Development542.5K1.4M352.8K83.8K
 
 
 
 
 
Total Operating Expenses4.9M4.9M2.2M1.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-4.6M-4.7M-2.1M-1.3M
 
 
 
 
 
Extraordinary Credit0.000.00421.3K0.00
 
 
Extraordinary Charge0.000.00-146.0K-124.5K
 
 
 
Interest Expense On Debt19.7K20.0K659.6K1.9M
 
 
 
 
 
Other Expenses-1.6K-5.6K-4.3K-402.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-4.6M-4.7M-2.5M-3.7M
 
 
 
 
 
Income Taxes0.000.000.00-4.0K
 
 
Net Income-4.6M-4.7M-2.5M-3.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS25.4M38.2M39.1M43.5M
 
 
 
 
 
Shares To Calculate EPS Diluted25.4M38.2M39.1M43.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.18-$0.12-$0.06-$0.09
 
 
 
 
 
EPS Diluted-$0.18-$0.12-$0.06-$0.09